MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

Search

Microbot Medical Inc

Uždarymo kaina

2.09 -2.79

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.09

Max

2.15

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-77K

-3.6M

Darbuotojai

20

EBITDA

-79K

-3.6M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+312.74% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-03-23

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

2.7M

143M

Ankstesnė atidarymo kaina

4.88

Ankstesnė uždarymo kaina

2.09

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

Microbot Medical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-15 18:44; UTC

Pagrindinės rinkos jėgos

Agenus Falls After $141 Million Zydus Deal Closes

2026-01-15 17:51; UTC

Pagrindinės rinkos jėgos

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

2026-01-15 17:25; UTC

Pagrindinės rinkos jėgos

ASML Exceeds $500 Billion in Market Value on TSMC's Blockbuster Spending Plans -- Update

2026-01-15 23:48; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-01-15 23:48; UTC

Rinkos pokalbiai

Nikkei May Decline as Enthusiasm Over Election Eases -- Market Talk

2026-01-15 23:40; UTC

Rinkos pokalbiai

Gold Edges Lower Amid Abating Geopolitical Risks -- Market Talk

2026-01-15 23:11; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-01-15 23:11; UTC

Rinkos pokalbiai

Ryman Healthcare's Resales Remain Key Concern -- Market Talk

2026-01-15 23:01; UTC

Rinkos pokalbiai

New Zealand's Economy Enters An Upswing -- Market Talk

2026-01-15 22:56; UTC

Rinkos pokalbiai
Uždarbis

Catalyst Metals Delivers a Beat With Record Gold Output -- Market Talk

2026-01-15 22:51; UTC

Rinkos pokalbiai

James Hardie's Plant Closures Could Boost Profit by 2%-3% -- Market Talk

2026-01-15 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Verizon Gets Final California Approval to Secure $9.6 Billion Frontier Deal -- WSJ

2026-01-15 21:50; UTC

Rinkos pokalbiai
Uždarbis

Financial Services Roundup: Market Talk

2026-01-15 21:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Energy & Utilities Roundup: Market Talk

2026-01-15 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-01-15 21:27; UTC

Uždarbis

BlackRock Caps 2025 With Record $14 Trillion in Assets -- 3rd Update

2026-01-15 21:15; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Global Commodities Roundup: Market Talk

2026-01-15 21:11; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Global Equities Roundup: Market Talk

2026-01-15 21:11; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Canada Antitrust Watchdog Confirms Review of Canadian Energy Deal -- Market Talk

2026-01-15 20:10; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Settle Mixed -- Market Talk

2026-01-15 20:04; UTC

Uždarbis

These Stocks Are Today's Movers: TSMC, ASML, Goldman, Morgan Stanley, BlackRock, Coinbase, Sandisk, and More -- Barrons.com

2026-01-15 20:03; UTC

Rinkos pokalbiai

Oil Futures Fall As Iran Risk Premium Fades -- Market Talk

2026-01-15 19:26; UTC

Rinkos pokalbiai

Silver Closes at Fresh High -- Market Talk

2026-01-15 18:29; UTC

Pagrindinės rinkos jėgos

Agenus Falls After $141M Zydus Deal Closes

2026-01-15 18:20; UTC

Uždarbis

Wall Street Powers Nation's Biggest Banks to Record Year -- WSJ

2026-01-15 17:56; UTC

Rinkos pokalbiai
Uždarbis

U.S. Bank Results Look Encouraging for European Peers -- Market Talk

2026-01-15 17:20; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Auto & Transport Roundup: Market Talk

2026-01-15 17:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-01-15 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-01-15 17:02; UTC

Įsigijimai, susijungimai, perėmimai

KBC Group Completes Acquisition of 98.45% Stake in 365.bank From J&T Finance Group

Akcijų palyginimas

Kainos pokytis

Microbot Medical Inc Prognozė

Kainos tikslas

By TipRanks

312.74% į viršų

12 mėnesių prognozė

Vidutinis 8.75 USD  312.74%

Aukščiausias 12 USD

Žemiausias 5.5 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Microbot Medical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

2

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

2.52 / 2.57Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Neutral Evidence

Vidutinės trukmės periodas

Very Strong Bullish Evidence

Ilgalaikis periodas

Weak Bullish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
help-icon Live chat